DE69739062D1 - Verwendung von kryptischen Peptiden zur Induktion von immunologischer Toleranz - Google Patents
Verwendung von kryptischen Peptiden zur Induktion von immunologischer ToleranzInfo
- Publication number
- DE69739062D1 DE69739062D1 DE69739062T DE69739062T DE69739062D1 DE 69739062 D1 DE69739062 D1 DE 69739062D1 DE 69739062 T DE69739062 T DE 69739062T DE 69739062 T DE69739062 T DE 69739062T DE 69739062 D1 DE69739062 D1 DE 69739062D1
- Authority
- DE
- Germany
- Prior art keywords
- immunological tolerance
- induce immunological
- cryptic peptides
- cryptic
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000001900 immune effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9605904.3A GB9605904D0 (en) | 1996-03-21 | 1996-03-21 | Peptides |
GBGB9608430.6A GB9608430D0 (en) | 1996-04-24 | 1996-04-24 | Peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69739062D1 true DE69739062D1 (de) | 2008-12-04 |
Family
ID=26308965
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69739062T Expired - Lifetime DE69739062D1 (de) | 1996-03-21 | 1997-03-20 | Verwendung von kryptischen Peptiden zur Induktion von immunologischer Toleranz |
DE69733343T Expired - Lifetime DE69733343D1 (de) | 1996-03-21 | 1997-03-20 | Kryptische peptide und verfahren zu ihrer identifizierung |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69733343T Expired - Lifetime DE69733343D1 (de) | 1996-03-21 | 1997-03-20 | Kryptische peptide und verfahren zu ihrer identifizierung |
Country Status (11)
Country | Link |
---|---|
US (1) | US6737406B1 (de) |
EP (2) | EP1612555B1 (de) |
JP (1) | JP4340329B2 (de) |
AT (2) | ATE412175T1 (de) |
AU (1) | AU730198C (de) |
CA (1) | CA2247009C (de) |
DE (2) | DE69739062D1 (de) |
DK (1) | DK1612555T3 (de) |
ES (1) | ES2314515T3 (de) |
GB (3) | GB2349463B (de) |
WO (1) | WO1997035193A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2812087B1 (fr) | 2000-07-21 | 2007-05-11 | Inst Nat Sante Rech Med | Procede de criblage de peptides utilisables en immunotherapie |
WO2002066979A1 (fr) * | 2001-02-22 | 2002-08-29 | Takara Bio Inc. | Procede de detection d'un antigene responsable de l'asthme |
PL371675A1 (en) * | 2002-06-11 | 2005-06-27 | Merck Patent Gmbh | Method for mapping and eliminating t-cell epitopes |
GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
US9340580B2 (en) * | 2007-08-15 | 2016-05-17 | Circassia Limited | Peptide with multiple epitopes |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2633881B2 (ja) | 1986-06-30 | 1997-07-23 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫調節組成物及びそれらの使用 |
US5019384A (en) | 1986-06-30 | 1991-05-28 | Massachusetts Institute Of Technology | Immunonodulating compositions and their use |
US6180368B1 (en) | 1988-03-23 | 2001-01-30 | University Of Melbourne | Ryegrass pollen allergen |
WO1990011293A1 (en) | 1989-03-17 | 1990-10-04 | Immulogic Pharmaceutical Corporation | Allergenic proteins from ragweed and uses therefor |
US5328991A (en) | 1989-11-03 | 1994-07-12 | Immulogic Pharmaceutical Corp. | Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes |
US5547669A (en) | 1989-11-03 | 1996-08-20 | Immulogic Pharma Corp | Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I |
US6019972A (en) | 1989-11-03 | 2000-02-01 | Immulogic Pharmaceutical Corporation | Peptides of human T cell reactive feline protein (TRFP) |
CA2073045C (en) * | 1989-11-03 | 2007-05-22 | Malcolm L. Gefter | A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
US5433948A (en) | 1990-02-13 | 1995-07-18 | Thomas; Wayne R. | Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
WO1992004445A1 (en) | 1990-09-11 | 1992-03-19 | The Western Australian Research Institute For Child Health Ltd. | Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
AU1272292A (en) | 1990-10-30 | 1992-05-26 | Immulogic Pharmaceutical Corporation | Peptide binding assays with mhc antigens |
WO1992011859A1 (en) | 1991-01-08 | 1992-07-23 | Immulogic Pharmaceutical Corporation | Peptide-mediated hyposensitization of the human t cell response to dermatophagoides spp. (house dust mite) |
EP0595855A1 (de) | 1991-07-12 | 1994-05-11 | Immulogic Pharmaceutical Corporation | Allergenische proteine und peptide von japanischen zederpollen |
WO1994001560A1 (en) | 1991-07-12 | 1994-01-20 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from japanese cedar pollen |
EP0610335B1 (de) * | 1991-10-16 | 2008-01-02 | Merck Patent GmbH | Verfahren zum Entwurf von Rekombitopen Peptiden |
WO1994024281A1 (en) | 1993-04-14 | 1994-10-27 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
HU220462B1 (hu) | 1991-10-16 | 2002-02-28 | Immulogic Pharmaceutical Corp. | A Dermatophagoides nemzetség allergénjéből származó peptidek, ezeket tartalmazó gyógyszerkészítmények és eljárás házi poratka-érzékenység kimutatására |
IL105153A (en) * | 1992-03-25 | 1999-12-22 | Immulogic Pharma Corp | Therapeutic compositions comprising peptides derived from human t cell reactive feline protein |
JPH07507924A (ja) | 1992-04-09 | 1995-09-07 | イミュロジック ファーマスーティカル コーポレイション | アンブロシア・アルテミシフォリア由来の主要アレルゲンのt細胞エピトープ |
WO1994003478A1 (en) | 1992-07-31 | 1994-02-17 | Immulogic Pharmaceutical Corporation | Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen |
CA2148713A1 (en) | 1992-11-12 | 1994-05-26 | Mei-Chang Kuo | Allergenic proteins and peptides from japanese cedar pollen |
ATE318902T1 (de) | 1992-12-31 | 2006-03-15 | Immulogic Pharma Corp | Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung |
AU684501B2 (en) | 1993-03-12 | 1997-12-18 | Immulogic Pharmaceutical Corporation | T cell epitopes of ryegrass pollen allergen |
JPH09509135A (ja) * | 1993-06-02 | 1997-09-16 | ティーヴィダブリュー テレソン インスティテュート フォー チャイルド ヘルス リサーチ | 免疫寛容の誘導における利用のためのクリプティックペプチド |
WO1995001597A2 (en) | 1993-07-01 | 1995-01-12 | British Telecomm | System for generating instructions for speech application |
JPH09504167A (ja) | 1993-08-13 | 1997-04-28 | イミュロジック ファーマスーティカル コーポレイション | ドクムギ花粉アレルゲンのt細胞エピトープ |
CA2186873A1 (en) | 1994-04-01 | 1995-10-12 | Charles J. Hackett | Haptenated peptides and uses thereof |
KR100379161B1 (ko) | 1994-04-14 | 2003-06-11 | 이뮤로직 파마시티컬 코포레이션 | 집먼지진드기에의한알레르기를치료하기위한의학적펩티드조성물 |
NZ273815A (en) | 1994-09-02 | 1999-05-28 | Immulogic Pharma Corp | Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides |
HUT77047A (hu) | 1994-10-25 | 1998-03-02 | Immulogic Pharmaceutical Corporation | Szklerózis multiplex kezelésére szolgáló készítmények és kezelések |
WO1996013589A1 (en) | 1994-10-27 | 1996-05-09 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from ambrosia artemisiifolia |
WO1996020950A2 (en) | 1995-01-06 | 1996-07-11 | Immulogic Pharmaceutical Corporation | Compositions and methods for treating rheumatoid arthritis |
DE69738962D1 (de) | 1996-03-10 | 2008-10-16 | Meiji Dairies Corp | Auf peptiden basierendes immunotherapeutisches mittel gegen allergien |
US5804201A (en) | 1996-03-11 | 1998-09-08 | The Rockefeller University | Immunomodulatory peptides of vespid antigen 5 |
-
1997
- 1997-03-20 EP EP05011041A patent/EP1612555B1/de not_active Expired - Lifetime
- 1997-03-20 CA CA002247009A patent/CA2247009C/en not_active Expired - Lifetime
- 1997-03-20 ES ES05011041T patent/ES2314515T3/es not_active Expired - Lifetime
- 1997-03-20 DE DE69739062T patent/DE69739062D1/de not_active Expired - Lifetime
- 1997-03-20 WO PCT/GB1997/000783 patent/WO1997035193A1/en active IP Right Grant
- 1997-03-20 EP EP97908389A patent/EP0888541B1/de not_active Expired - Lifetime
- 1997-03-20 GB GB0020260A patent/GB2349463B/en not_active Expired - Fee Related
- 1997-03-20 DK DK05011041T patent/DK1612555T3/da active
- 1997-03-20 GB GB9817461A patent/GB2326642B/en not_active Expired - Lifetime
- 1997-03-20 US US09/142,885 patent/US6737406B1/en not_active Expired - Lifetime
- 1997-03-20 AT AT05011041T patent/ATE412175T1/de active
- 1997-03-20 DE DE69733343T patent/DE69733343D1/de not_active Expired - Lifetime
- 1997-03-20 AU AU20365/97A patent/AU730198C/en not_active Expired
- 1997-03-20 GB GB0027373A patent/GB2352518B/en not_active Expired - Fee Related
- 1997-03-20 AT AT97908389T patent/ATE296444T1/de not_active IP Right Cessation
- 1997-03-20 JP JP53327097A patent/JP4340329B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB2352518A (en) | 2001-01-31 |
GB2352518B (en) | 2001-04-04 |
CA2247009C (en) | 2009-08-04 |
AU730198C (en) | 2002-03-14 |
CA2247009A1 (en) | 1997-09-25 |
JP4340329B2 (ja) | 2009-10-07 |
GB2326642B (en) | 2001-02-07 |
EP1612555B1 (de) | 2008-10-22 |
DK1612555T3 (da) | 2009-02-09 |
GB2326642A (en) | 1998-12-30 |
EP1612555A1 (de) | 2006-01-04 |
EP0888541B1 (de) | 2005-05-25 |
GB2349463B (en) | 2001-01-10 |
JP2000508627A (ja) | 2000-07-11 |
GB0020260D0 (en) | 2000-10-04 |
WO1997035193A1 (en) | 1997-09-25 |
AU730198B2 (en) | 2001-03-01 |
ES2314515T3 (es) | 2009-03-16 |
EP0888541A1 (de) | 1999-01-07 |
DE69733343D1 (de) | 2005-06-30 |
GB2349463A (en) | 2000-11-01 |
ATE296444T1 (de) | 2005-06-15 |
AU2036597A (en) | 1997-10-10 |
GB0027373D0 (en) | 2000-12-27 |
GB9817461D0 (en) | 1998-10-07 |
US6737406B1 (en) | 2004-05-18 |
ATE412175T1 (de) | 2008-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69427370D1 (de) | Neue integrinbindende peptide | |
HU9501276D0 (en) | Stabile, liophylised composition containing proteins | |
DE4393381T1 (de) | Peptide | |
ATE76309T1 (de) | Dialyseloesung und ihre herstellung unter verwendung von peptiden auf der basis von glycin. | |
DK6893D0 (da) | Peptid | |
DE69129865T2 (de) | Osteogene peptide | |
DE69333921D1 (de) | "enhancer" sequenz zur modulation der expression in epithelialzellen | |
SE8803847A0 (sv) | Neuromodulerande peptid | |
ATE412175T1 (de) | Verwendung von kryptischen peptiden zur induktion von immunologischer toleranz | |
DE69427363D1 (de) | Plättchenaggregationsinhibierende peptide | |
KR900011856A (ko) | 혼성 아미노 수지 조성물 | |
ZA946887B (en) | Novel proteins/polypeptides and cotransfection plasmics and live recombinant carriers therefor | |
DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
KR900011857A (ko) | 혼성 아미노 수지 조성물 | |
DK0779297T3 (da) | Antigene peptider med glycinsubstitutioner | |
NO177858C (no) | Peptid | |
KR900011855A (ko) | 혼성 아미노 수지 조성물 | |
DE69420044T2 (de) | Blutregulierende peptide | |
IT9019021A0 (it) | Composizioni a base di prolina,glicina e lisina per il trattamento della carenza di collagene | |
ATE310083T1 (de) | Deprenyl induziertes protein | |
DE69030316T2 (de) | Schrittweiser c-terminaler abbau von peptiden und proteinen | |
SE9602361D0 (sv) | Plant proteins/peptides | |
DK136088D0 (da) | Peptid | |
GB9412147D0 (en) | Recombinant binding proteins and peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |